AbbVie & IGI Ink Global Deal For ISB 2001 Licensing Rights
12 Jul 2025 //
PRESS RELEASE
ISB 2001 Shows High Response Rates and Safety in Multiple Myeloma
02 Jun 2025 //
GLOBENEWSWIRE
Ichnos Glenmark Gets Fast Track for ISB 2001 For Multiple Myeloma
05 May 2025 //
GLOBENEWSWIRE
Ichnos Glenmark Presents Data on ISB 2001 for Myeloma at ASH
05 Nov 2024 //
GLOBENEWSWIRE